Literature DB >> 1891480

The dynamics of drug resistance in Plasmodium falciparum.

W H Wernsdorfer1, D Payne.   

Abstract

Drug resistance of Plasmodium falciparum is not a recent phenomenon, but it became a major problem when the parasite became resistant to chloroquine, the cheapest and initially the most effective antimalarial compound that could be used for treatment and suppression. In some areas this problem is compounded by resistance to the first line of alternative drugs, and rapid loss of sensitivity to the next line. The dynamics of drug resistance are regulated mainly by drug related selection pressure and intensity of malaria transmission. Mass drug administration in its various forms, and insufficient treatment are obviously the most important motors of selection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891480     DOI: 10.1016/0163-7258(91)90074-v

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  49 in total

1.  Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum.

Authors:  Ulrike Sponer; Somsak Prajakwong; Gerhard Wiedermann; Herwig Kollaritsch; Gunther Wernsdorfer; Walther H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 2.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

3.  Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2020

4.  Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India.

Authors:  Tonya Mixson-Hayden; Vidhan Jain; Andrea M McCollum; Amanda Poe; Avinash C Nagpal; Aditya P Dash; Jonathan K Stiles; Venkatachalam Udhayakumar; Neeru Singh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

5.  Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Authors:  Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

6.  Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.

Authors:  L K Basco; R Tahar; P Ringwald
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

7.  Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.

Authors:  S R Hawley; P G Bray; P M O'Neill; D J Naisbitt; B K Park; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

8.  Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province, China.

Authors:  Ruimin Zhou; Chengyun Yang; Suhua Li; Yuling Zhao; Ying Liu; Dan Qian; Hao Wang; Deling Lu; Hongwei Zhang; Fang Huang
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 9.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

10.  Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.